Nonlipid-lowering effects of statins

@article{Sorrentino2005NonlipidloweringEO,
  title={Nonlipid-lowering effects of statins},
  author={Sajoscha A. Sorrentino and Ulf Landmesser},
  journal={Current Treatment Options in Cardiovascular Medicine},
  year={2005},
  volume={7},
  pages={459-466}
}
Optional statementStatins have been shown to effectively reduce cardiovascular events in patients with hypercholesterolemia, diabetes, and coronary disease, and after an acute coronary syndrome in several large-scale clinical trials. Interestingly, numerous studies have suggested that statins exert potentially important effects independent of lipid lowering (ie, improve endothelial function, reduce oxidant stress), and have direct antiinflammatory, antithrombotic, and plaque-stabilizing effects… 
Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering.
TLDR
Better understanding of the mechanisms that underlie endothelial dysfunction could lead to the design of novel therapeutic strategies that target the vascular endothelium for the prevention and treatment of CVD.
Rapid, Direct Effects of Statin Treatment on Arterial Redox State and Nitric Oxide Bioavailability in Human Atherosclerosis via Tetrahydrobiopterin-Mediated Endothelial Nitric Oxide Synthase Coupling
TLDR
This study demonstrates for the first time in humans the direct effects of statin treatment on the vascular wall, supporting the notion that this effect is independent of low-density lipoprotein lowering.
Clinical prospects for dyslipidemia treatment in patients with arterial hypertension
Background: Epidemiological research data shows that the prevalence of arterial hypertension among the adult population in the developed countries varies from 20% to 40% and increases with age.
Statins in dermatology
TLDR
The various cellular and molecular effects of statins, their applications in cutaneous medicine and their side effects are reviewed.
Coming full circle in diabetes mellitus: from complications to initiation
TLDR
This Review will examine how the development of diabetes mellitus has come full circle from initiation to complications and suggests that the development and progression to chronic complications both require the same mechanistic triggers.
Statins Attenuate the Increase in P-Selectin Produced by Prolonged Exercise
TLDR
It is concluded that statins blunt the exercise-induced increase in p-selectin following a marathon and that the inflammatory response to a marathon varies directly with LDL-C levels.
Role of lipotoxicity in endothelial dysfunction.
TLDR
The current understanding of molecular and physiologic mechanisms underlying lipotoxicity-mediated endothelial dysfunction as well as relevant therapeutic approaches to ameliorate dyslipidemia and consequent endothelium dysfunction that have the potential to improve cardiovascular and metabolic outcomes are discussed.
Mechanisms of diabetic complications.
TLDR
The well validated, as well as putative mechanisms involved in the development of diabetic complications are discussed and new fields of research, which warrant further investigation as potential therapeutic targets of the future, will be highlighted.
The roles of nitric oxide and hydrogen sulfide in the anti-atherosclerotic effect of atorvastatin
TLDR
ATV significantly ameliorates atherosclerotic lesions and enhances the activity of serum nitric oxide system, but not H2S system, which significantly weakens antiatherosclerosis of ATV.
Previous Statin Use and High-Resolution Magnetic Resonance Imaging Characteristics of Intracranial Atherosclerotic Plaque: The Intensive Statin Treatment in Acute Ischemic Stroke Patients With Intracranial Atherosclerosis Study
TLDR
Premorbid statin usage is independently associated with reduced plaque enhancement and a decrease in large cortical lesions in patients with intracranial atherosclerotic stroke.
...
1
2
3
...

References

SHOWING 1-10 OF 53 REFERENCES
Statins and Stroke
  • M. Endres
  • Medicine
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
  • 2005
TLDR
Retrospective clinical evidence suggests that long-term statin administration may not only reduce stroke risk but also improve outcome and early secondary prevention trials are underway to test the hypothesis that statin treatment initiated immediately after an event improves short-term outcome.
Simvastatin Versus Ezetimibe: Pleiotropic and Lipid-Lowering Effects on Endothelial Function in Humans
TLDR
Four weeks of simvastatin treatment improves endothelial function independently of LDL cholesterol lowering, at least in part by reducing oxidant stress.
Short-Term Statin Therapy Improves Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy
TLDR
Short-term statin therapy improves cardiac function, neurohormonal imbalance, and symptoms associated with idiopathic dilated cardiomyopathy and suggest that statins may have therapeutic benefits in patients with heart failure irrespective of serum cholesterol levels or atherosclerotic heart disease.
Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure.
TLDR
Investigating the impact of hydroxymethylglutaryl coenzyme A reductase inhibitor (statin) therapy in patients with advanced heart failure found it associated with improved survival without the necessity of urgent transplantation in both non-ischemic and ischemic HF patients.
Inflammation and Atherosclerosis
TLDR
New insights into inflammation in atherosclerosis not only increase the understanding of this disease, but also have practical clinical applications in risk stratification and targeting of therapy for this scourge of growing worldwide importance.
Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.
TLDR
In this prospective trial, pravastatin reduced CRP levels at both 12 and 24 weeks in a largely LDL-C-independent manner, providing evidence that statins may have anti-inflammatory effects in addition to lipid-lowering effects.
Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
Completed randomized trials of statin therapy demonstrate that 3-hydroxy-3-methylglutaryl–coenzyme A (HMG-CoA) reductase inhibitors reduce the risk of myocardial infarction, stroke, and other
Effect of pravastatin on outcomes after cardiac transplantation.
TLDR
After cardiac transplantation, pravastatin had beneficial effects on cholesterol levels, the incidence of rejection causing hemodynamic compromise, one-year survival, andThe incidence of coronary vasculopathy.
C-Reactive Protein Levels and Outcomes after Statin Therapy
TLDR
Relationships between the LDL cholesterol and CRP levels achieved after treatment with 80 mg of atorvastatin or 40 mg of pravastatin per day and the risk of recurrent myocardial infarction or death from coronary causes among 3745 patients with acute coronary syndromes are evaluated.
Simvastatin Exerts Both Anti-inflammatory and Cardioprotective Effects in Apolipoprotein E—Deficient Mice
TLDR
Simvastatin attenuates leukocyte-endothelial cell interactions and ameliorates ischemic injury in hypercholesterolemic mice independently of lipid-lowering actions.
...
1
2
3
4
5
...